A machine learning model using FDG-PET imaging to accurately predict Alzheimer’s-type tau pathology across spectrums of aging and dementia is developed, providing a novel framework to estimate tau burden non-invasively.
Nick Corriveau-Lecavalier, Ge-Meng Zhang, H. Botha et al.· Nature Communications· 0 citations
Abstract Clinical syndromes of frontotemporal dementia present both distinct and overlapping neuroimaging abnormalities and, consequently, domains of impairment. The aim of this study was to determine how well covariance patterns from multiple neuroimaging modalities discriminate across clinical frontotemporal dementia...
Irene Sintini, Neha Singh-Reilly, Farwa Ali et al.· Brain Communications· 0 citations
Abstract INTRODUCTION We compared the association between mild behavioral impairment (MBI) and first‐ versus second‐generation tau‐positron emission tomography (PET) tracers in preclinical and prodromal Alzheimer's disease (AD). METHODS We assessed 110 individuals with head‐to‐head [18F]MK6240 and [18F]Flortaucipir tau...
I. Bizzi, Arthur C. Macedo, Lydia Trudel et al.· Alzheimer's & Dementia· 0 citations
Key Points Question Can a harmonized visual reading framework enable reliable, tracer-agnostic staging of tau positron emission tomography (PET) pathology for clinical use? Findings In this multicenter cross-sectional study of 681 participants scanned with multiple tau PET radiotracers, a 5-class harmonized visual read...
E. Ruppert, M. Vermeiren, Marina Scop Medeiros et al.· JAMA Neurology· 0 citations
Background/Objectives: The role of iron in Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) has been debated. However, the effects of iron on protein burden in these diseases remain poorly elucidated. We hypothesized that there is an association between iron deposition and tau and beta-amyloid depo...
Rodolfo Gabriel Gatto, Hossam Youssef, Gökhan Uruk et al.· Brain Science· 0 citations
It is shown that elevated plasma GFAP significantly modulates the association between p-tau217 and both cross-sectional cognitive severity and longitudinal clinical decline, and support that astrocyte reactivity is associated with greater cognitive impairment and faster clinical decline among individuals with elevated...
B. Bellaver, G. Povala, P. C. L. Ferreira et al.· Molecular Neurodegeneration· 0 citations
White matter microstructural disruption is a dominant imaging signature of CBS and is more closely linked to gray matter volume loss than to measurable uptake on tau PET, while dMRI, particularly MD and ICVF, may provide greatest sensitivity for detecting disease-related changes in CBS.
Yu-Qi Tian, Ryota Satoh, V. Lowe et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.